Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Mars orbiter sees 'butterfly' crater spread its wings on the Red Planet - 2Putin says Russian forces will seize capital of Zaporizhzhya
- 3Peloton recalls more than 800,000 bikes after broken seat posts injure users
- 4Poll: 62% of Americans would oppose U.S. military action in Greenland
- 5Home Wellness Basics: Building Your Home Exercise center
- The Craft of Computerized Detox: Individual Trials
- Is Trump going to war with Venezuela?
- US students studying housing, health outcomes and sustainability win 2026 Rhodes scholarships
- Purchases of iPhone 17 Pro soar across Gaza amid 'limited' humanitarian aid
- Defense Minister Katz moves to extend IDF service to 36 months
- Huge solar flare no threat to Artemis 2 astronaut launch to the moon, NASA says
- Careful Living: Embracing the Current Second
- Home Machine Basics: An Exhaustive Purchasing Guide
- Underestimated Metropolitan Experience Urban communities On the planet
